Member of the Association of American Physicians
Steven E. Kahn focuses on Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Type 2 diabetes. His research is interdisciplinary, bridging the disciplines of Placebo and Internal medicine. Endocrinology is frequently linked to Pathogenesis in his study.
Steven E. Kahn combines subjects such as Physical therapy and Hazard ratio with his study of Diabetes mellitus. His Insulin research integrates issues from Adipose tissue, Hypothalamus and Metabolism. His research investigates the connection with Type 2 diabetes and areas like Weight loss which intersect with concerns in Overweight and Incidence.
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin. Internal medicine is represented through his Insulin resistance, Impaired glucose tolerance, Obesity, Glucose tolerance test and Body mass index research. His Insulin resistance research incorporates elements of Waist and Cholesterol.
His Diabetes mellitus study frequently draws connections to other fields, such as Research design. His Type 2 diabetes research includes elements of Clinical trial, Weight loss, Overweight, Randomized controlled trial and Physical therapy. His work deals with themes such as Secretion, Carbohydrate metabolism and Arginine, which intersect with Insulin.
His primary scientific interests are in Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Insulin. His Internal medicine research includes elements of Placebo and Prediabetes. His Diabetes mellitus study which covers Prospective cohort study that intersects with Weight change and Family history.
His Type 2 diabetes research is multidisciplinary, incorporating elements of Metformin, Obesity and Glycemic. The Endocrinology study combines topics in areas such as Genetically modified mouse and Transgene. His Insulin research incorporates elements of Adipose tissue and Immune system.
Steven E. Kahn spends much of his time researching Internal medicine, Diabetes mellitus, Type 2 diabetes, Insulin and Insulin resistance. His Internal medicine study combines topics in areas such as Endocrinology, Nephropathy and Linagliptin. In most of his Endocrinology studies, his work intersects topics such as Amyloid.
His work on Glycemic is typically connected to Coronavirus as part of general Diabetes mellitus study, connecting several disciplines of science. Steven E. Kahn has included themes like Metformin, Research design and Insulin sensitivity, β cell function in his Type 2 diabetes study. Steven E. Kahn combines subjects such as Adipose tissue and Prediabetes with his study of Insulin resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn;Rebecca L. Hull;Kristina M. Utzschneider.
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Kahn Se;Haffner Sm;Heise Ma;Herman Wh.
The New England Journal of Medicine (2006)
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
S. E. Kahn.
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.
Miriam Cnop;P. J. Havel;K. M. Utzschneider;D. B. Carr.
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.
S E Kahn;R L Prigeon;D K McCulloch;E J Boyko.
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
R. R. Wing;P. Bolin;F. L. Brancati;G. A. Bray.
The New England Journal of Medicine (2013)
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Steven E Kahn;Mark E Cooper;Stefano Del Prato.
The Lancet (2014)
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
Rena R. Wing;Judy L. Bahnson;George A. Bray;Jeanne M. Clark.
JAMA Internal Medicine (2010)
Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity
Utpal B. Pajvani;Meredith Hawkins;Terry P. Combs;Michael W. Rajala.
Journal of Biological Chemistry (2004)
Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome
Darcy B. Carr;Kristina M. Utzschneider;Rebecca L. Hull;Keiichi Kodama.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: